Handelsbanken Fonder’s Instil Bio TIL Stock Holding History

Handelsbanken Fonder’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-875	Closed	-$12K	–	1626
2023 Q1	$12K	Hold	875	–	–	﹤0.01%	1562
2022 Q4	$11K	Hold	875	–	–	﹤0.01%	1556
2022 Q3	$85K	Hold	875	–	–	﹤0.01%	1539
2022 Q2	$81K	Sell	875 -225	-20%	-$31.9K	﹤0.01%	1594
2022 Q1	$236K	Hold	1,100	–	–	﹤0.01%	1597
2021 Q4	$376K	Buy	+1,100	New	+$425K	﹤0.01%	1526

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Handelsbanken Fonder's TIL Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 875 shares — an estimated $12K sold.

Handelsbanken Fonder first reported a position in TIL in Q4 2021 and held it in 6 quarters. The position peaked at $376K in Q4 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

Handelsbanken Fonder reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
Handelsbanken Fonder sold 875 Instil Bio shares in Q2 2023, an estimated $12K.
Handelsbanken Fonder first reported a position in Instil Bio in Q4 2021 and held it in 6 quarters.
Handelsbanken Fonder's Instil Bio position peaked at $376K in Q4 2021.
62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.